Patient and Media Reports




MSTranslate interviews patient as part of a MIS416 Clinical Trial special feature


The video below is one of a series of interviews carried out by MSTranslate.  MSTranslate is an independent, curated multiple sclerosis information resource.  MSTranslate have recently posted a feature on their website in relation to the Company's MIS416 clinical program for patients with secondary progressive multiple sclerosis (SPMS). The feature includes video interviews with the Company's Managing Director and the Chief Scientific Officer and with patients who have been accessing MIS416 on compassionate grounds in New Zealand. Click here to view this feature on the MSTranslate website



Channel 7 Perth - SPMS Trial


Patients with Secondary Progressive Multiple Sclerosis (SPMS) talk about MIS416


Biotech Nation